SEC 13F Intelligence

Managers / Q3 2023 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$198M
Q3 2023
Positions
33
Filings on Record
30
2019–present window
Filed
Nov 7, 2023
original filing

Summary

Sivik Global Healthcare LLC reported $198M in U.S.-listed holdings across 33 positions for Q3 2023.

Its largest position, HCA, represents 5.0% of the portfolio.

Compared with Q2 2023, the fund opened 2 new positions and exited 12.

Portfolio Metrics

Turnover
+7.0%
vs prior filed quarter
Top-10 Concentration
+42.0%
share of reported value
Largest Position
+5.0%
Hca Healthcare
New / Exited
2 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 91.0%ADR: 4.1%ETP: 3.7%Other: 1.1%
  • Common Stock · 91.0% · $180M
  • ADR · 4.1% · $8M
  • ETP · 3.7% · $7M
  • Other · 1.1% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
DXCMDexcom IncNEW+50.0K50.0K+$5M$5M
PODDInsulet CorpNEW+20.0K20.0K+$3M$3M
AVTRAvantor IncADDED+105.0K180.0K+$2M$4M
SPYSPDR S&P 500 ETF TrustSOLD OUT−400.0K0−$177M$0
BDXBecton Dickinson & CoSOLD OUT−30.0K0−$8M$0
ELVElevance Health IncSOLD OUT−15.0K0−$7M$0
ABTAbbott LaboratoriesSOLD OUT−60.0K0−$7M$0
MRKMerck & Co IncSOLD OUT−50.0K0−$6M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2023

33 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1HCAHCA Healthcare Inchistory →COM4.97%$10M40.0K
2THCTenet Healthcare Corphistory →COM NEW4.66%$9M140.0K
3HUMHumana Inchistory →COM4.30%$9M17.5K
4BSXBoston Scientific Corphistory →COM4.27%$8M160.0K
5NVONovo Nordisk A/Shistory →ADR4.14%$8M90.0K
6UHSUniversal Health Services Inchistory →CLASS B4.13%$8M65.0K
7LLYEli Lilly & Cohistory →COM4.07%$8M15.0K
8MCKMcKesson Corphistory →COM3.85%$8M17.5K
9UNHUnitedHealth Group Inchistory →COM3.82%$8M15.0K
10SYKStryker Corphistory →COM3.80%$8M27.5K
11XBISPDR S&P Biotech ETFhistory →S&P BIOTECH3.69%$7M100.0K
12CICigna Group/Thehistory →COM3.61%$7M25.0K
13DHRDanaher Corphistory →COM3.45%$7M27.5K
14ISRGIntuitive Surgical Inchistory →COM NEW3.32%$7M22.5K
15CORCencora Inchistory →COM3.18%$6M35.0K
16MDTMedtronic PLChistory →SHS3.17%$6M80.0K
17EHCEncompass Health Corphistory →COM3.05%$6M90.0K
18ZBHZimmer Biomet Holdings Inchistory →COM2.84%$6M50.0K
19TMOThermo Fisher Scientific Inchistory →COM2.69%$5M10.5K
20ACHCAcadia Healthcare Co Inchistory →COM2.66%$5M75.0K
21CAHCardinal Health Inchistory →COM2.63%$5M60.0K
22SGRYSurgery Partners Inchistory →COM2.59%$5M175.0K
23S24Select Medical Holdings Corphistory →COM2.46%$5M192.3K
24BAXBaxter International Inchistory →COM2.38%$5M125.0K
25DXCMDexcom Inchistory →COM2.36%$5M50.0K
26BMRNBioMarin Pharmaceutical Inchistory →COM2.24%$4M50.0K
27VRTXVertex Pharmaceuticals Inchistory →COM2.19%$4M12.5K
28AVTRAvantor Inchistory →COM1.92%$4M180.0K
29Catalent IncCOM1.84%$4M80.0K
30IQVIQVIA Holdings Inchistory →COM1.74%$3M17.5K
31PODDInsulet Corphistory →COM1.61%$3M20.0K
32ICLRICON PLChistory →SHS1.24%$2M10.0K
33Stevanato Group SpAORD SHS1.14%$2M76.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.